Gilead Sciences Stock (GILD) After Hours: What to Know Before the Market Opens on Dec. 24, 2025
Gilead Sciences shares closed up 0.83% at $125.19 on Dec. 23, 2025, then held steady after hours. The company announced it will exclusively license Assembly Biosciences’ herpes drug candidates, expanding its antiviral pipeline. U.S. markets will close early on Dec. 24, with thin trading expected. Investors are watching for headlines and Gilead’s upcoming J.P. Morgan Healthcare Conference appearance.